Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Lenti in red: progress in gene therapy for human hemoglobinopathies
Christof von Kalle, … , Christopher Baum, David A. Williams
Christof von Kalle, … , Christopher Baum, David A. Williams
Published October 1, 2004
Citation Information: J Clin Invest. 2004;114(7):889-891. https://doi.org/10.1172/JCI23132.
View: Text | PDF
Commentary Article has an altmetric score of 3

Lenti in red: progress in gene therapy for human hemoglobinopathies

  • Text
  • PDF
Abstract

Hemoglobinopathies are caused by abnormal structure or synthesis of hemoglobin chains and represent serious monogenic disorders. A new study demonstrates that lentiviral vectors can express clinically relevant levels of human transgenic β-globin in red cells of xenografted mice. While some safety concerns must be addressed, this study is an important step toward potential clinical trials of gene therapy for hemoglobinopathies.

Authors

Christof von Kalle, Christopher Baum, David A. Williams

×

Total citations by year

Year: 2009 2008 Total
Citations: 5 1 6
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (6)

Title and authors Publication Year
Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome
D Wang, W Zhang, TA Kalfa, G Grabowski, S Davies, P Malik, D Pan
Proceedings of the National Academy of Sciences 2009
A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction
A Perumbeti, T Higashimoto, F Urbinati, R Franco, HJ Meiselman, D Witte, P Malik
Blood 2009
Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region
PI Arumugam, T Higashimoto, F Urbinati, U Modlich, S Nestheide, P Xia, C Fox, A Corsinotti, C Baum, P Malik
Molecular Therapy 2009
Supplying Clotting Factors From Hematopoietic Stem Cell–derived Erythroid and Megakaryocytic Lineage Cells
M Sadelain, A Chang, L Lisowski
Molecular Therapy 2009
The sea urchin sns5 insulator protects retroviral vectors from chromosomal position effects by maintaining active chromatin structure.
D'Apolito D, Baiamonte E, Bagliesi M, Di Marzo R, Calzolari R, Ferro L, Franco V, Spinelli G, Maggio A, Acuto S
Molecular Therapy 2009
miR-181a-mediated gene regulation segregates T lineage expression of transgenic antigen receptors in hematopoietic chimeras
Eirini P Papapetrou, Damian Kovalovsky, Laurent Beloeil, Derek Sant’Angelo, and Michel Sadelain
Journal of Clinical Investigation 2008

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
3 readers on Mendeley
See more details